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E-mail address: oliver.mueller@fh-kl.de (O. MüllerThe Wnt pathway regulates cell proliferation, mobility and differentiation. Among the many Wnt
target genes is CCND1 which codes for cyclin D1. Cyclin D1, in complex with cdk4 and cdk6, regulates
G1/S phase transition during cell cycle. Independently of CDK, cyclin D1 also regulates the migration
of macrophages. Here we analyzed the effects of cyclin D1 on the migration of cancer cell lines using
the transwell migration and scratch assays. We also tested the effect of cyclin D1 and b-catenin on E-
cadherin-mediated cell–cell contacts. Our results show that the Wnt pathway promotes cellular
migration via its target gene cyclin D1. Moreover we show that cyclin D1 inﬂuences the actin cyto-
skeleton and destabilizes adherens junctions.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction
The canonical Wnt pathway plays an important role in the cel-
lular proliferation and differentiation and leads to tumor formation
when aberrantly activated [1]. If no Wnt signal is present, the
proto-oncoprotein b-catenin is bound by a multiprotein complex
consisting of the proteins adenomatous polyposis Coli (APC), axin
or conductin/axin2, the serine-threonine kinases casein kinase 1
(CK1) and glycogen synthase kinase-3b (GSK-3b). In this so-called
destruction complex b-catenin is phosphorylated and therefore
marked for ubiquitination via b-transducin repeat containing pro-
tein (b-TrCP) and the subsequent proteasomal degradation, so the
level of free b-catenin in the cytosol is kept low. In cells with active
pathway the destruction complex is destabilized. As a consequence
b-catenin is no longer bound and phosphorylated. So b-catenin
accumulates in the cytoplasm and translocates into the nucleus
where it binds to transcription factors of the T-cell factor/lymphoid
enhancer factor (TCF/LEF) family. The binding of b-catenin replaces
co-repressors and recruits other co-activators to the promoter [2].
Beside its function in the activation of theWnt pathway, there is
a second pool of b-catenin at the plasma membrane. Here it playsal Societies. Published by Elsevier
lied Sciences Kaiserslautern,
brücken, Germany. Fax: +49
).an important role in the formation of E-cadherin-mediated cell–
cell contacts, as it connects proteins of the adherens junctions with
the actin cytoskeleton [3]. On the one hand b-catenin interacts
with the cytoplasmic domain of E-cadherin and on the other hand
it also binds a-catenin, an actin-binding protein. Recent studies
have shown that this complex is rather dynamic, because a-cate-
nin cannot bind E-cadherin and b-catenin at the same time [4–6].
Adherens junctions are involved in the epithelial–mesenchymal
transition (EMT) during tumor formation. One hallmark of EMT is
the loss of function of E-cadherin, which results in the dissociation
of the E-cadherin–b-catenin–a-catenin complex from the mem-
brane [7–11]. The loss of E-cadherin-mediated cellular adhesion
leads to an increased b-catenin dependent transcription [12–14]
and is associated with a poor prognosis [15–17].
CCND1, which encodes the cyclin dependent kinase (cdk) acti-
vator cyclin D1 was found as a Wnt target gene in several systems,
e.g. in human colorectal cancer cells [18,19] and human teratocar-
cinoma cells [20]. In other studies, however, these results were not
conﬁrmed [21–23].
The central role of cyclin D1 is the regulation of G1/S phase
transition in the cell cycle [24–27]. In complex with cdk4 and
cdk6 cyclin D1 integrates extracellular signals and mitogens into
cell cycle progression [28]. There are also some cdk4- and cdk6-
independent functions of cyclin D1. Among these are the inhibition
of transcription factors like SP1 [29], cyclin D1-binding myb-like
protein 1 (DMPI) [30] and nuclear receptors like the androgenB.V. Open access under CC BY-NC-ND license.
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(PPARc) [33] and the thyroid hormone receptor [34]. Moreover cy-
clin D1 seems to inﬂuence the migration of cells in a cdk-indepen-
dent manner. Macrophages of Ccnd1/ mice show an increased
cellular adhesion compared to macrophages from wild type mice.
As a consequence the migration of these macrophages is impaired
[35]. The pro-migratory effect of cyclin D1 is due to the inhibition
of the rho-associated, coiled-coil containing protein kinase 2
(ROCK2) and thrombospondin-1 (TSP1), which both inhibit the
migration of cells [36]. Among the substrates of ROCK2 and TSP1
are the kinases MLC and LIM, which both lead to the formation
of stress ﬁbers and thus to a decreased migration rate.
2. Materials and methods
2.1. Cell lines and cell cultivation
The colorectal carcinoma cell lines HCT116, SW480 and the
cervix carcinoma cell line HeLa were purchased from ATCC-LGC
(Wesel, Germany). HCT116 cells harbor activating mutations in
the Wnt and the Ras pathway. Due to the deletion of the serine
coding codon 45 in the b-catenin coding gene CTNNB1 the phos-
phorylation of b-catenin by the kinase CKIa/e is not possible
[37]. Furthermore the proto-oncogene KRAS is mutated at codon
13 leading to the constitutive activation of the proliferation acti-
vating Ras pathway in HCT116 cells. SW480 cells have no func-
tional APC protein [38] based on a non-sense mutation at codon
1338 of the ﬁrst allele leading to a truncated APC protein and the
LOH of the second allele. HeLa cells were originally established
from a HPV-18 infected cervical carcinoma. The viral infection
led to the inactivation of the p53/Rb tumor suppressor network.
Cell lines were cultured at 37 C and 7.5% CO2 in a humidiﬁed
atmosphere in Dulbecco’s Modiﬁed Eagle Medium (DMEM). The
medium was supplemented with 10% (v/v) fetal calf serum (FCS),
penicillin (2.85 U/ml) and streptomycin (2.85 lg/ml), L-glutamine
(11.4 mM), non-essential amino acids (0.57 mM) and sodium pyru-
vate (11 nM). Cell growth was controlled by light microscopy, and
cell number was determined with a hemocytometer.
2.2. Transient siRNA transfection
siRNA was purchased from Dharmacon (distributed by Perbio,
Bonn, Germany). Among these siRNAs were cyclin D1 siGENOME
SMARTpool, c-myc siGENOME SMARTpool and the b-catenin
siGENOME SMARTpool. As a control siCONTROL non-targeting #1
was used. Cells were transfected using the transfection reagent
DharmaFECT 1 (Dharmacon) by following the protocol of the man-
ufacturer. DharmaFECT contains non-ionic and cationic lipids,
which form liposome complexes with the negative charged siRNA.
After fusion with the cell membrane these complexes are ingested
by endocytosis.
2.3. Transwell migration assay
The migration rate of cells was determined with the QCM
chemotaxis 96-well cell migration assay (Millipore, Schwalbach,
Germany) by following the supplied protocol. The migration assay
was performed 48 h after siRNA transfection. Cells were incubated
with serum-free medium 12 h previously. Medium with 10% FCS
was used as attractant.
2.4. Scratch assay
Migration of HeLa cells was also tested with a scratch assay.
Cells were cultured in 3.5 cm plates, transfected with siRNA and48 hours after transfection the conﬂuent monolayer was scratched
with a tip to produce a 100–150 lm cell free scratch. After washing
the cells the scratch was documented every hour over a period of
14 hours (Leitz Labovert).
2.5. Immunocytochemistry and ﬂuorescence microscopy
The actin cytoskeleton was stained with phalloidin/TRITC (Sig-
ma Aldrich, München, Germany). Cells were washed with phos-
phate buffered saline (PBS) and ﬁxed by incubation for 20 min in
formaldehyde (3.7% in PBS). After this the cells were washed with
PBS and permeabilized in cold acetone/methanol (1:1) for 5 min at
20 C and air-dried for 10 min at room temperature (RT). Unspe-
ciﬁc antigens were blocked by incubation in blocking solution (1%
milk powder in PBS) for 15 min at RT. After washing the cells were
incubated with phalloidin/TRITC (1:1000 in PBS with 0.5%
Tween20, PBS/T) for 1 h at RT. Cells were again washed with PBS
and the cell nuclei were counterstained in 0.05 lg/ml DAPI (4,6-
diamidin-2-phenylindol) in PBS for 5 min. After washing with
PBS the cells were mounted on slides with ﬂuorescent mounting
medium (Dako, Glostrup, Denmark). Analysis and evaluation were
performed with the microscope Axiophot (Zeiss, Oberkochen,
Germany) and the software Axiovision Release 4.6.3.
E-cadherin-mediated cell–cell junctions were visualized with
an anti-E-cadherin antibody (Dianova, Hamburg). Cells were
washed with PBS and ﬁxed as described above. After ﬁxation in
formaldehyde cells were permeabilized in 1% Triton x-100 in PBS
for 10 min at RT. Unspeciﬁc antigens were blocked by incubation
in blocking solution (2% BSA in PBS) for 30 min. Primary
anti-E-cadherin antibody was added at a 1:100 dilution in blocking
solution and incubated for 1 h at RT. Cells were washed twice with
PBS and incubated with the secondary anti-mouse-Cy3 antibody
(GE Healthcare, München, Germany) at a 1:100 dilution in blocking
solution again for 1 h at RT. After washing with PBS cells were trea-
ted as indicated above.
2.6. Flow cytometry
Cells were cultured in 10 cm plates, transfected with siRNA and
harvested 48 h after transfection. Cells were centrifuged for 5 min
at 1500 rpm and resuspended in PBS. Fixation and permeabiliza-
tion of 106 cells were performed with commercial reagents (BD
Cytoﬁx/Cytoperm Fixation/Permeabilization Kit from Becton
Dickinson, Heidelberg, Germany) by following the protocol of the
manufacturer. Staining of the actin cytoskeleton with phalloidin/
FITC was performed as described above for phalloidin/TRITC in
ﬂuorescence microscopy. Cells were analyzed by FACS (LSRII from
Becton Dickinson) and data were evaluated with the software
FlowJo (TreeStar Inc., Ashland, USA).
3. Results
3.1. Cyclin D1 and b-catenin promote cellular migration
The inﬂuence of the Wnt pathway and cyclin D1 on cellular
migration was tested using the cell lines HCT116, SW480 and HeLa.
The cells were transfected with cyclin D1 and b-catenin siRNA and
a transwell migration assay was performed (Fig. 1).
In this assay cyclin D1 siRNA treated cells showed a signiﬁcant
decrease up to 67% in the migration rate. Transfection with b-cate-
nin siRNA led to an inhibition of at least 20%. In SW480 cells
b-catenin siRNA treatment showed no effect on cellular migration.
A scratch assay with HeLa cells was performed (Fig. 2). In this
assay the results of the transwell migration assay could be con-
ﬁrmed, as the migration was inhibited after cyclin D1 siRNA and
Fig. 1. Knock-down of cyclin D1 and b-catenin lowers relative migration rate. Bars show relative migration rates after siRNA transfection. The migration rate of control cells,
which were treated with control siRNA, was set as 100%. The statistical analysis was performed with the Student’s t-test. ⁄ indicates P < 0.005, ⁄⁄ indicates P < 0.05.
Fig. 2. HeLa cells are impaired in their migration after treatment with siRNA against b-catenin or cyclin D1. Representative photographs of the cellular migration in the
scratch assay after 6 and 13 h. Control cells were transfected with control siRNA.
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ent monolayer after 6 h, in cyclin D1 and b-catenin siRNA transfec-
ted cells the scratch was closed after 10 and 13 h, respectively.
These results indicate that the Wnt pathway promotes cellular
migration via its target gene cyclin D1.
3.2. Cyclin D1 and b-catenin inﬂuence the actin cytoskeleton
To investigate the effect on cellular migration in more detail the
inﬂuence of the Wnt pathway and cyclin D1 on the actin cytoskel-
eton was analyzed. Cells were transfected with siRNA against
b-catenin or cyclin D1 and stained with TRITC- or FITC-coupled
phalloidin. Subsequently, the cells were investigated with the help
of immunoﬂuorescence microscopy (Fig. 3) or ﬂow cytometry
(Fig. 4), respectively.
The ﬂuorescence microscopic analysis showed a rearrangement
of the actin cytoskeleton after cyclin D1 siRNA transfection in alltested cell lines. Treatment with b-catenin siRNA inﬂuenced the ac-
tin cytoskeleton in HCT116 and HeLa cells, but not in SW480 cells
(Fig. 3 and unshown data).
Next, the ﬂuorescence intensity of phalloidin/FITC was quanti-
ﬁed using ﬂow cytometry. Results showed that cyclin D1 siRNA
and b-catenin siRNA treatment of HCT116 cells and cyclin D1 siR-
NA transfection of SW480 cells lead to an increased mean ﬂuores-
cence intensity (MFI) (Fig. 4). As a conclusion cyclin D1 either
inhibits actin polymerization or promotes actin depolymerization
in colorectal cancer cells.
3.3. Cyclin D1 and b-catenin destabilize E-cadherin-mediated
adherens junctions
Furthermore the effects of cyclin D1 and b-catenin siRNA trans-
fection on the formation of E-cadherin-mediated adherens junc-
tions were analyzed via ﬂuorescence microscopy. Therefore cells
Fig. 3. The actin cytoskeleton rearranges after knock-down of cyclin D1 or b-catenin. Immunoﬂuorescences of siRNA treated and phalloidin/TRITC (red) stained HCT116 cells.
Control cells were transfected with control siRNA. Nuclei are counterstained with DAPI (blue).
Fig. 4. Cyclin D1 inﬂuences polymerization of the actin cytoskeleton in colorectal cancer cells. Flow cytometry analysis of phalloidin/FITC stained and siRNA treated HCT116
and SW480 cells. Representative histograms for cyclin D1 (blue) and b-catenin siRNA (green) transfected cells are shown (A). As a control the cells were either treated with
control siRNA (gray) or were left untreated and unstained (black). (B) Quantiﬁcation of the relative mean ﬂuorescence intensity (MFI).
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HCT116 and SW480 cells showed an increase in the number ofadherens junctions after cyclin D1 and b-catenin siRNA treatment
(Fig. 5). In HeLa cells no effect could be observed (data not shown).
Fig. 5. Formation of E-cadherin-mediated adherens junctions in HCT116 and SW480 cells after transfection with siRNA against cyclin D1 or b-catenin. Immunoﬂuorescences
of siRNA treated and E-cadherin/Cy3 (red) stained HCT cells and SW480 cells. As a control the cells were transfected with control siRNA. Nuclei are marked with DAPI (blue).
White arrows show E-cadherin-mediated cellular contacts.
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Increased migration and decreased adhesion of cells are impor-
tant hallmarks in advanced carcinogenesis, as both contribute to
the ability of tumor cells to destabilize the intercellular context
and to metastasize. The actin cytoskeleton is directly located under
the cell membrane and is important for a number of biological
functions in eukaryotic cells. It determines the form and polarity
of cells, regulates cell division and plays a role in migration [39].
The movement of cells can be divided into three phases. First,
the protrusion of the leading edge when the cell reorganizes the
actin network at this side. Second, the adhesion of the cell to the
substrate at the leading edge and the de-adhesion at the cell body
and rear of the cell. Finally, the movement of the cell body, when
contractile forces of the acto-myosin network pull the cell forward
[40]. The actin cytoskeleton is regulated by different members of
the family of Rho GTPases. The best characterized are RhoA, Rac1
and Cdc42. RhoA induces stress ﬁbers, which play an important
role in cell contraction, and is also involved in the formation of
adhesion plaques, which are essential for cell–substrate contacts.
Rac1 is associated with the formation of lamellipodias and Cdc42
mediates the polymerization of actin to ﬁlopodias [39].
The study presented here shows a signiﬁcant inﬂuence of the
Wnt pathway and namely cyclin D1 on cellular migration. Cyclin
D1 promotes the migration of both colorectal and cervical carci-
noma cell lines, whereas an effect of b-catenin was only visible
in HCT116 and HeLa cells but not in the second tested colorectal
cancer cell line SW480. The same was observed in the polymeriza-
tion of the actin cytoskeleton, where b-catenin has no inﬂuence in
SW480 cells but in HCT116 and HeLa cells. So the inﬂuence of the
Wnt signaling pathway via cyclin D1 on cellular migration might
be due to effects on the polymerization or depolymerization of
the actin cytoskeleton. It is known, that macrophages and MEFs
(mouse embryonic ﬁbroblasts) of cyclin D1 deﬁcient mice show
an increased cellular adhesion and an impaired migration com-
pared to those of wild type mice [35]. Li et al. [36] could show that
the inﬂuence of cyclin D1 on cellular migration is due to the tran-
scriptional inhibition of ROCK2 and TSP1, which are involved in the
formation of stress ﬁbers and therefore inhibit migration. These re-
sults could not be conﬁrmed in our study via quantitative real-time
RT-PCR (data not shown). There was no inﬂuence of cyclin D1 onthe transcription of ROCK2 and TSP1 found in the tested colorectal
and cervical cancer cell lines. Therefore cyclin D1 promotes cellular
migration via an alternative mechanism. The cdk inhibitor p27Kip1
is involved in the inhibition of cellular proliferation of normal cells.
In cancer cells p27Kip1 often translocates from the nucleus to the
cytoplasm. Here it is not degraded like other tumor suppressors,
but acts as a regulator of the cytoskeleton and cell migration
[41–43]. p27Kip1 binds to RhoA and inhibits the interaction with
the activating GEF [44]. Moreover it has been shown that p21 binds
and inhibits the RhoA effectors ROCK1 and -2 in the cytoplasm
[45]. Furthermore another cdk inhibitor, p57Kip2, binds to the ki-
nase LIMK1 without affecting the activity directly. Instead, the
interaction leads to the nuclear localization of the kinase and con-
sequently to its inhibition [46]. These studies suggest that proteins
of the Cip/Kip family inhibit the Rho signaling pathway at different
sites. As a consequence there is a reduction in the formation of
Rho-induced stress ﬁbers and focal adhesions. In this model cyclin
D1 promotes cellular migration by rescuing p27Kip1 from degrada-
tion, increasing the amount of this protein. Future studies should
measure the activity of the actin cytoskeleton regulating proteins
RhoA, Rac1 and Cdc42 to elucidate the role of cyclin D1 on cell
migration.
E-cadherinmediates cellular adhesion and the formation of cell–
cell contacts, as it connects proteins of adherens junctions with the
actin cytoskeleton [3]. During carcinogenesis the cells undergo the
epithelial–mesenchymal transition, which is characterized by the
loss of these cell–cell contacts resulting in an increased motility
[15,16]. The results of this study show that an aberrantly activated
Wnt pathway destabilizes E-cadherin-mediated cell–cell contacts
via cyclin D1. As a consequence the integrity of the cell layer is dis-
turbed and the invasion of tumor cells facilitated.
In conclusion, the results presented here indicate that cyclin D1
inﬂuences the movement of cancer cells by promoting cell migra-
tion and destabilizing adherens junctions.
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